Fauci Awards Package (Redacted) — page 14

give talks about their work over the course of their careers, rather than current science and theory, and $1 million is far outside of the range of typical honoraria paid for individual presentations. From videos available on the internet (at sites not presently blocked by NIH security measures), it appears that the Prize ceremony is quite elaborate, well-attended, and in keeping with what we expect such an event to "look like." Press reports that coincide with the announcement of each year's winners appear to reflect that this is a significant award/honor. Gretchen H. Weaver, J.D. Supervisory/Senior NIH Ethics Counsel DHHS/OGC/Ethics Division phone: fax: NOTICE: THIS E-MAIL MESSAGE FROM THE OFFICE OF THE GENERAL COUNSEL (OGC), ETHICS DIVISION IS INTENDED FOR THE EXCLUSIVE USE OF THE RECIPIENT(S) NAMES ABOVE AND MAY CONTAIN PROTECTED, PRIVILEGED, OR CONFIDENTIAL INFORMATION THAT SHOULD NOT BE TRANSMITTED TO UNAUTHORIZED ADDRESSEES. IF YOU ARE NOT THE INTENDED RECIPIENT, ANY DISSEMINATION, DISTRIBUTION, OR COPYING IS STRICTLY PROHIBITED. IF YOU HAVE RECEIVED THIS E-MAIL IN ERROR, PLEASE NOTIFY THE SENDER IMMEDIATELY AT THE ABOVE ADDRESS. EMPLOYEE RECIPIENTS ARE COUNSELED THAT DISCIPLINARY ACTION FOR VIOLATING FEDERAL ETHICS REGULATIONS MAY NOT BE TAKEN AGAINST ANY EMPLOYEE WHO HAS ENGAGED IN CONDUCT IN GOOD FAITH RELIANCE UPON THE PRIOR ADVICE OF ANY AGENCY ETHICS OFFICIAL, PROVIDED THAT THE EMPLOYEE HAS MADE FULL DISCLOSURE OF ALL RELEVANT CIRCUMSTANCES. IF EMPLOYEE CONDUCT IS POTENTIALLY SUBJECT TO CRIMINAL SANCTIONS UNDER CONFLICT OF INTEREST AND RELATED STATUTES, RELIANCE OF THE ADVICE OF AN AGENCY ETHICS OFFICIAL IN INTERPRETING THE SCOPE OF SUCH STATUTES IS A FACTOR THAT MAY BE TAKEN INTO ACCOUNT BY THE DEPARTMENT OF JUSTICE IN EXERCISING PROSECUTORIAL DISCRETION. EMPLOYEES ARE CAUTIONED THAT DISCLOSURES TO AN OGC ATTORNEY ARE NOT PROTTECTED WITHIN THE DEPARTMENT BY ATTORNEY-CLIENT PRIVILEGE. ALL EMPLOYEES, INCLUDING AGENCY ATTORNEYS, ARE REQUIRED TO REPORT CRIMINAL VIOLATIONS TO THE OFFICE OF THE INSPECTOR GENERAL. From: Jaffe, Holli Beckerman (NIH/OD) [E] @od.nih.gov> Sent: Friday, January 29, 2021 2:16 PM To: Weaver, Gretchen (NIH/OD) [E] < @od.nih.gov> Subject: FW: Dan David Prize My quick thoughts From: Jaffe, Holli Beckerman (NIH/OD) [E] Sent: Friday, January 29, 2021 11:40 AM To: Tabak, Lawrence (NIH/OD) [E] < @nih.gov> Cc: Schwetz, Tara (NIH/OD) [E] @nih.gov> Subject: Dan David Prize I'm lost as to what Tony wants you to raise with HHS at this VERY early time. It's not a pending HHS matter yet, though once we transmit the package, HHS could be helpful in telling OGC that this is a top priority (and not clearing other OPDIVs' appointees). NEO needs time to assemble the package. From a quick review of the website, I know we'll need to contact the award sponsor for additional information. For example: Laureates in each selected field are chosen by the Dan David Prize Board, based on the recommendations of International Review Committees comprised of world-renowned experts in the relevant fields. Will need to confirm that both the Review Committee and the DD Board used written selection criteria, either the same or different. Also need to know who makes up the Committee and Board (so can likely prove both are independent of Tel Aviv U.) Nomination requirements include: "A detailed description of the nominee's work (1-2 pages), stipulating reasons why the nominee merits the Dan David Prize. Reference should be made to the importance of the work, its impact and its projected influence in the relevant field." Might be able to use "importance of the work, its impact and its projected influence in the relevant field," are selection criteria. Would need sponsor to confirm that selections are based on these factors.